<DOC>
	<DOC>NCT01871961</DOC>
	<brief_summary>To evaluate the human factors/usability of Rheumatoid Arthritis (RA) patients with the MetojectÂ® prefilled pen (including a label comprehension assessment and a device robustness evaluation).</brief_summary>
	<brief_title>Evaluation of Patient Performance Using the Metoject Device for Subcutaneous Injection in Rheumatoid Arthritis (RA)Patient</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Is a suitable candidate for treatment with Methotrexate for Rheumatoid Arthritis Male or female patient who is 16 years of age or older Is a female patient who is pregnant, trying to become pregnant, or breast feeding, or of childbearing potential, sexually active and not practicing a highly reliable method of birth control during the study and at least 6 months thereafter Has any history of hypersensitivity to the investigational medicinal product Has a history of or current inflammatory arthritis or rheumatic autoimmune disease other than Rheumatoid Arthritis (RA) Is unable to comprehend written labeling and training materials</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>